4118

KANEKA CORPORATION

カネカ

Industry
Chemicals
Market
Prime
Accounting standards
Japanese GAAP
Consolidation basis
Consolidated

Key metrics

Revenue(million JPY)

Mar 2021
577,426
Mar 2022
691,530
Mar 2023
755,821
Mar 2024
762,302
Mar 2025
807,200

Operating profit(million JPY)

Mar 2021
27,544
Mar 2022
43,562
Mar 2023
35,087
Mar 2024
32,579
Mar 2025
40,050

Operating profit margin(%)

Mar 2021
4.77
Mar 2022
6.3
Mar 2023
4.64
Mar 2024
4.27
Mar 2025
4.96

Profit before tax(million JPY)

Mar 2021
22,201
Mar 2022
36,405
Mar 2023
32,373
Mar 2024
36,808
Mar 2025
36,770

Profit(million JPY)

Mar 2021
15,831
Mar 2022
26,487
Mar 2023
23,008
Mar 2024
23,220
Mar 2025
25,309

Total assets(million JPY)

Mar 2021
667,429
Mar 2022
726,959
Mar 2023
782,640
Mar 2024
870,205
Mar 2025
920,143

Cash and cash equivalents(million JPY)

Mar 2021
46,360
Mar 2022
40,712
Mar 2023
40,699
Mar 2024
43,278
Mar 2025
44,631

Cash flows from operating activities(million JPY)

Mar 2021
74,040
Mar 2022
34,106
Mar 2023
28,710
Mar 2024
61,911
Mar 2025
41,252

Cash flows from investing activities(million JPY)

Mar 2021
-43,229
Mar 2022
-39,595
Mar 2023
-41,970
Mar 2024
-58,771
Mar 2025
-55,038

Cash flows from financing activities(million JPY)

Mar 2021
-21,903
Mar 2022
-1,105
Mar 2023
12,352
Mar 2024
-1,519
Mar 2025
14,453

Return on equity(%)

Mar 2021
4.6
Mar 2022
7.1
Mar 2023
5.7
Mar 2024
5.3
Mar 2025
5.5

Equity ratio(%)

Mar 2021
53.5
Mar 2022
53.3
Mar 2023
53.3
Mar 2024
52.1
Mar 2025
51.2

Earnings per share(JPY per share)

Mar 2021
242.68
Mar 2022
406.01
Mar 2023
349.59
Mar 2024
357.9
Mar 2025
400.91

Net assets per share(JPY per share)

Mar 2021
5,473.85
Mar 2022
5,934.36
Mar 2023
6,431.63
Mar 2024
7,068.91
Mar 2025
7,488.51

Dividend per share(JPY per share)

Mar 2021
100
Mar 2022
110
Mar 2023
110
Mar 2024
110
Mar 2025
130

Payout ratio(%)

Mar 2021
41.21
Mar 2022
27.09
Mar 2023
31.47
Mar 2024
30.73
Mar 2025
32.43

Disclaimer

The financial information and metrics on this page are based on publicly available filings and other public sources. We do not guarantee their accuracy, completeness, or timeliness.

The information on this page is provided for reference purposes only and does not constitute a recommendation to buy or sell any security. Investment decisions should be made at your own responsibility.